Na-K ATPase activity through activation of at least two parallel pathways, the effects of which on Na-K ATPase vary depending on the duration of treatment (1-3, 9, 17, 38) . Short-term inhibition of Na-K ATPase activity by DA is dependent on stimulation of DA 1 and DA 2 receptors through activation of the phospholipase C (PLC)-PKC cascade. However, long-term inhibition of Na-K ATPase activity by DA occurs through a PKAdependent pathway. PTH also inhibits Na-K ATPase initially through activation of PKC (14, (39) (40) but through PKA-dependent pathways in the long term (38) . Both DA and PTH inhibit Na-K ATPase activity by the activation of calcium-independent phospholipase A 2 (PLA 2 ), which releases arachidonic acid (AA). AA is metabolized by cytochrome P-450 to -hydroxyeicosatetraenoic acid (20-HETE). 20-HETE regulates rat renal Na-K ATPase via PKC activation (34) .
Our laboratory has previously shown that, in opossum kidney (OK) cells, a model of renal proximal tubule, PTH and DA regulation of sodium-dependent phosphate transport differ in magnitude and duration despite activation of many similar signal transduction pathways (29) . We have attributed these differences to the fact that PTH and DA also activate some dissimilar pathways. PTH, but not DA, regulates sodium-dependent phosphate transport through activation of the mitogen-activated protein kinase, i.e., extracellular signal-regulated kinase (ERK) (30) . DA, but not PTH, inhibits sodium-dependent phosphate uptake by a pertussis toxin-sensitive pathway. In preliminary experiments, we have demonstrated that inhibition of Na-K ATPase by 1 M ouabain for 30 min inhibits sodiumdependent phosphate uptake (21.83 Ϯ 2.18 vs. 8.80 Ϯ 0.14 nmol P i ⅐ mg protein Ϫ1 ⅐ min Ϫ1 , n ϭ 2) in OK cells, confirming that Na-K ATPase activity contributes to sodium-dependent phosphate transport. We speculated that differences in the regulation of Na-K ATPase by PTH and DA could partially explain the differences in mechanisms of regulation of phosphate uptake by these agonists. The present study was undertaken to compare regulation of inhibition of Na-K ATPase by PTH and DA in OK cells. We hypothesized that PTH and DA would regulate Na-K ATPase through diver-gent signaling mechanisms, similar to differences in regulation of phosphate transport.
MATERIALS AND METHODS

Materials.
Wild-type OK cells were a generous gift from Dr. Steven Scheinman (Health Sciences Center, Syracuse, NY). Antibody against the ␣-subunit of the OK cell Na-K ATPase was obtained from RBI (Natick, MA). Phosphoserine antibody was purchased from Zymed Laboratories (San Francisco, CA). Antibodies to PKC isoforms were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Bovine parathyroid hormone [PTH(1O34)] was obtained from Bachem (Philadelphia, PA). DA, PD-098059, and calphostin C were purchased from Calbiochem. H89 was purchased from Biomol Research Laboratories (Plymouth, PA). Bromoenol lactone (BEL) and 20-HETE were obtained from Cayman Chemicals (Ann Arbor, MI). ATP, ouabain, AA, and ferrous sulfate were purchased from Sigma (St. Louis, MO). Other reagents were of the highest quality available.
Cell culture. Wild-type OK cells, passages 83-89, were grown as monolayers in 175-cm 2 plastic flasks (Falcon) or 3 ϫ 10-mm tissue culture plates (Nunc) in Eagle's medium with Earle's salts (GIBCO BRL Life Technologies, Grand Island, NY) supplemented with 10% heat-inactivated fetal calf serum, 4 mM glutamine, 100 g/ml streptomycin, and 100 IU/ml penicillin in a humidified 5% CO 2-95% air environment at 37°C. They were fed three times a week and split 1:4 once a week by trypsinization and dispersal. Cells were used for experiments at 100% confluence. They were washed the evening before use. For experiments requiring preincubation with specific inhibitor agents, these agents were added for the designated period of time at 37°C, followed by the addition of the signaling pathway activator also for the designated period of time. The inhibitor was present during the entire incubation period. The reaction was stopped by washing with ice-cold Hanks' basic salt solution (HBSS) followed by homogenization. Phosphatase inhibitors were not present.
Membrane isolation. The cells were washed twice with HBSS and homogenized in 300 mM mannitol-5 mM Tris-HEPES buffer, pH 7.6, using a 27.5-G needle. The cell lysate was centrifuged at 2,000 rpm for 10 min to remove the cell debris, and crude membranes were isolated by centrifugation of the supernatant at 17,000 rpm for 30 min. The pellet was resuspended in 300 mM mannitol-5 mM Tris-HEPES buffer, pH 7.6.
Protein determination. Protein concentration was determined by a DC protein kit (Bio-Rad) using BSA as standard.
Determination of Na-K ATPase activity. The activity of Na-K ATPase was determined in OK cell membranes by the method of Szczepanska-Konkel et al. (43) . The cell membranes (50 g protein) were incubated for 15 min at 37°C in medium containing in a final volume of 1.5 ml (final concentration in mM) 4.8 ATP, 120 NaCl, 24 KCl, 7.2 MgSO 4, and 48 Tris ⅐ HCl, pH 7.6, with or without 1.2 mM ouabain. The reaction was terminated with 0.3 ml 30% TCA. The difference in the ATPase activity assayed in the absence and presence of ouabain is taken as a measure of Na-K ATPase. Na-K ATPase activity is expressed as nanomoles P i released per milligram protein per hour.
Determination of P i. Pi released due to the action of Na-K ATPase was determined by the method of Tausky and Shorr (44) in protein-free supernatant. One milliliter of the supernatant was diluted to 1.8 ml with glass-distilled water, and 1.2 ml of ferrous sulfate reagent [5 gm FeSO 4 dissolved in 10% (wt/vol) ammonium molybdate in 10 N H2SO4] was added. A calibration curve was prepared simultaneously with the test samples, using known concentrations of KH 2PO4 (9-180 nmol Pi) and 4.8 mM ATP. The blue color obtained was read at 820 nm after a 20-min incubation at room temperature in a Hewlett Packard 8453 spectrophotometer against a reagent blank.
Isolation of basolateral membranes. The cells were grown on inserts in a six-well plate. After they reached confluence, the cells were treated with 10 Ϫ7 M PTH(1O34), 10 Ϫ6 M PTH(3O34), or 10 Ϫ5 M DA on both sides of the inserts. The inserts were washed with Tris-buffered NaCl (154 mM). The cells were lysed in 50 mM mannitol-5 mM Tris-HEPES buffer, pH 7.0, and homogenized using a high-speed homogenizer (Powergen 125, Fisher Scientific). MgCl2 was added in a final concentration of 10 mM to the homogenate and incubated for 20 min on ice with occasional stirring. The homogenate was centrifuged at 2,500 g for 5 min at 4°C. The pellet was resuspended in 100 mM Mannitol-5 mM Tris-HEPES buffer, and MgCl2 was added to a final concentration of 15 mM. The suspension was incubated for 20 min on ice with occasional stirring and centrifuged at 2,500 g for 5 min. The pellet was again resuspended in 100 mM mannitol-5 mM Tris-HEPES buffer, pH 7.4, and centrifuged at 750 g for 15 min. The supernatant was removed and centrifuged at 48,000 g in an Ultracentrifuge (Beckman) for 30 min. The pellet derived from centrifugation of the supernatant was resuspended in 50% sucrose, using a dounce homogenizer. The sample was overlaid on a discontinuous sucrose gradient, made by mixing 12 ml 38% sucrose with 5 ml 41% sucrose, and centrifuged at 88,000 g in an Ultracentrifuge (Beckman) for 3 h. The upper layer was carefully collected and resuspended in 1 mM bicarbonate buffer, pH 7.5, and centrifuged at 48,000 g in a Beckman Ultracentrifuge for 30 min. The pellet was resuspended in 300 mM mannitol-5 mM Tris-HEPES buffer, pH 7.4 (33) . The basolateral membranes were characterized by the five-to eightfold enrichment of Na-K ATPase (data not shown).
Immunoblots. OK cell membrane proteins were solubilized in Laemmli sample buffer, separated by 10% SDS-PAGE, and transferred electrophoretically to a nitrocellulose membrane. The nitrocellulose sheet was incubated with 5% milk in 20 mM Tris and 50 mM NaCl (TBS) at room temperature for 60 min, in an appropriate dilution of primary antibody in TBS with 0.2% Tween (TTBS) for at least 60 min at room temperature or overnight at 4°C, and an appropriate concentration of horseradish peroxidase-linked goat anti-rabbit IgG (or secondary antibody of appropriate species) for 50 min at room temperature, washed, and developed by chemiluminescence assay (Biolab). The developed blots were scanned and analyzed using a Meridian densitometer and expressed as densitometric units.
Immunoprecipitation of Na-K ATPase. The crude membranes were precleared with protein A-Sepharose beads for 2 h at 4°C and were incubated with 1 ng of rabbit polyclonal antibodies against the ␣-subunit of Na-K ATPase (Research Diagnostics, Flanders, NJ) overnight at 4°C. Protein A-Sepharose beads were added and incubated for 2 h at 4°C. The beads were washed three times with 1ϫ PBS, and an equal volume of 2ϫ Laemmli sample buffer was added and boiled for 5 min. The beads were centrifuged, and the proteins were separated by 10% SDS-PAGE, transferred to nitrocellulose membranes, and blotted against phosphoserine antibodies (Zymed Laboratories, San Francisco, CA).
Statistics. Data are shown as means Ϯ SE. The n values shown represent the number of separate experiments. Each experiment was done in triplicate. The P value was calculated using SigmaStat software utilizing Student's t-test. A P value Ͻ0.05 was a priori considered as statistically significant.
RESULTS
Effect of PKA and PKC activation on Na-K ATPase activity in OK cells. Activation of PKC decreases the activity of Na-K ATPase in proximal tubular cells. The effect of activation of PKA in proximal tubule cells is somewhat controversial, with some studies suggesting an increase in activity (10, 23) whereas others suggest a decrease (1, 9) . To determine the effect of activation of PKA or PKC on Na-K ATPase activity in OK cells, the cells were treated with 10 Ϫ6 M 8-bromoadenosine 3Ј,5Ј-cyclic monophosphate (8-BrcAMP), a phosphodiesterase-resistant cAMP analog that directly activates PKA, or 10 Ϫ4 M phorbol 12-myristate 13 acetate (PMA), a phorbol ester that directly activates PKC, for 15 min or 2 h. Activation of PKA by 8-BrcAMP caused a time-dependent decrease in the activity of Na-K ATPase. Activation of PKC by PMA caused maximum inhibition of Na-K ATPase activity after a 15-min incubation, and the degree of inhibition did not change after 2 h of treatment ( Fig. 1, A and B) .
PTH and DA inhibit Na-K ATPase in OK cells. In renal proximal tubules, PTH and DA regulate Na-K ATPase through biphasic signaling pathways. PTH inhibits Na-K ATPase activity by 15-30% after shortterm (15 min) (39, 40) and by 50% after long-term (2 h) incubation (38) . DA inhibits Na-K ATPase activity by 35-40% after short-and long-term incubation (1, 3, 9, 17, 38) . To confirm that these agonists had similar effects in OK cells, we measured Na-K ATPase activity in OK cell membranes after 15-min and 2-h incubation with 10 Ϫ7 M PTH(1O34) and 10 Ϫ5 M DA. PTH inhibited Na-K ATPase by 35% (21.00 Ϯ 1.37 vs. 13.74 Ϯ 0.46 nmol P i released ⅐ mg protein Ϫ1 ⅐ h Ϫ1 , n ϭ 3, P Ͻ 0.005) after 15 min and by 57% (22.45 Ϯ 1.82 vs. 9.73 Ϯ 0.99 nmol P i released ⅐ mg protein Ϫ1 ⅐ h Ϫ1 , n ϭ 3, P Ͻ 0.005) after 2-h incubation (Fig. 2, A and B) . DA resulted in 32% (21.00 Ϯ 1.37 vs. 14.25 Ϯ 0.41 nmol P i released ⅐ mg protein Ϫ1 ⅐ h Ϫ1 , n ϭ 3, P Ͻ 0.005) inhibition after 15 min and 59% (22.45 Ϯ 1.82 vs. 9.28 Ϯ 0.70 nmol P i released ⅐ mg protein Ϫ1 ⅐ h Ϫ1 , n ϭ 3, P Ͻ 0.005) inhibition of Na-K ATPase activity after 2 h incubation (Fig. 2, A and B) .
Signaling pathways involved in regulation of Na-K ATPase. In renal proximal tubules, PTH and DA inhibit Na-K ATPase activity through multiple signaling pathways. To examine the pathways responsible for PTH and DA inhibition of Na-K ATPase in OK cells, we measured Na-K ATPase inhibition in cells treated with specific inhibitors of several signaling pathways.
To determine whether DA and PTH regulate Na-K ATPase activity through a PKC-dependent mechanism, the cells were pretreated with 10 Ϫ6 M calphostin C for 30 min in the presence of light at 37°C, required for activation. Calphostin C alone had no significant effect on basal Na-K ATPase activity. Pretreatment with calphostin C completely blocked the ability of both PTH and DA to inhibit Na-K ATPase activity at 15 min (Fig. 3A) . Calphostin C caused less (60 and 60%) but still significant inhibition of the effect of both DA and PTH on Na-K ATPase activity after 2 h (Fig. 3B) . We confirmed these results in cells preincubated with another PKC inhibitor, Ro 81-322 (Ro; 10 Ϫ5 M) for 1 h before treatment with PTH or DA for 15 min or 2 h. Ro alone had no effect on Na-K ATPase activity after short-term (27.38 . Na-K ATPase activity was measured in the membranes as described in MATERIALS AND METHODS. Each assay was performed in triplicate, averaged, and considered as a single data point. Values are means Ϯ SE expressed as nmol Pi released ⅐ mg protein Ϫ1 ⅐ h Ϫ1 (n ϭ 3 separate experiments). *P Ͻ 0.01, Na-K ATPase activity significantly different from control.
of Na-K ATPase by PTH and DA is PKC dependent but that long-term inhibition is only partially PKC dependent.
To determine whether PTH or DA inhibited Na-K ATPase by a PKA-dependent mechanism, the cells were treated with 10 Ϫ4 M H-89, a PKA inhibitor, for 30 min before incubation with PTH and DA. H-89 at that concentration completely inhibited the activity of PKA as measured by a Peptag PKA kit (Promega; data not shown). H-89 alone did not significantly affect basal Na-K ATPase activity. Pretreatment with H-89 had no affect on the inhibition of Na-K ATPase activity by either PTH or DA after 15-min incubation (Fig. 4A ). However, pretreatment with H-89 caused significant attenuation of the effect of both PTH (83%) and DA (76%) on Na-K ATPase activity after 2-h incubation (Fig. 4B) . These results were confirmed in cells pretreated with the PKA inhibitor Rp diastereomer of cAMP (data not shown). The results indicate that short-term inhibition of Na-K ATPase by PTH and DA is independent of PKA. However, long-term inhibition of Na-K ATPase by PTH and DA is dependent on PKA activation.
Previous studies have demonstrated that DA and PTH inhibit the activity of Na-K ATPase through a PLA 2 pathway in renal proximal tubular cells. To determine whether DA and/or PTH regulates the activity of Na-K ATPase by the PLA 2 pathway in OK cells, the cells were treated for 10 min with 1 M/ml of the PLA 2 suicide inhibitor BEL before treatment with PTH and DA. BEL alone did not significantly change basal Na-K ATPase activity (data not shown). Pretreatment with BEL significantly attenuated the effect of both PTH (102 and 73%) and DA (104 and 84%) after 15-min and 2-h incubation, respectively (Fig. 5, A and B) . The results suggest that, similar to proximal tubular cells, in OK cells both PTH and DA inhibit Na-K ATPase activity through the activation of PLA 2 . Fig. 3 . Effect of calphostin C on the inhibition of Na-K ATPase activity by DA and PTH. OK cell monolayers in 35 ϫ 10-mm plates were incubated in medium containing vehicle, or 10 Ϫ6 M calphostin C for 30 min before treatment with 10 Ϫ5 M DA (D), or 10 Ϫ7 M PTH (P) for either 15 min (A) or 2 h (B). Na-K ATPase activity was measured in the membranes as described in MATERIALS AND METHODS. Each assay was performed in triplicate, averaged, and considered as a single data point. Values are means Ϯ SE expressed as nmol Pi released ⅐ mg protein Ϫ1 ⅐ h Ϫ1 (n ϭ 3 separate experiments). *P Ͻ 0.01, Na-K ATPase activity significantly different from control. We have previously demonstrated that PTH, but not DA, inhibits phosphate transport through an ERKdependent pathway (30) . To determine whether PTH or DA inhibited Na-K ATPase through an ERK-dependent pathway, Na-K ATPase activity was measured in OK cell membranes from cells pretreated with 10 Ϫ5 M PD-098059 [PD; an inhibitor of mitogen-activated protein kinase kinase (MEK)] for 60 min before treatment with PTH and DA. Pretreatment with PD significantly attenuated PTH inhibition of Na-K ATPase both after 15-min (106%) and 2-h (83%) incubation (Fig. 6, A and  B) . However, PD did not affect the inhibition of Na-K ATPase activity by DA after both 15-min and 2-h incubation. PD alone did not affect basal Na-K ATPase activity (Fig 6, A and B) . The results indicate that PTH, but not DA, inhibits Na-K ATPase through an ERKdependent pathway.
PTH receptors regulate Na-K ATPase in the proximal tubule through Gq/G 11 pathway, whereas DA inhibits Na-K ATPase activity through G i pathway. To determine whether similar pathways are activated in OK cells, OK cell monolayers were treated with 10 nM pertussis toxin (an inhibitor of G i ) overnight before treatment with PTH and DA. Pretreatment with pertussis toxin had no effect on basal activity of Na-K ATPase. Pertussis toxin partially but significantly inhibited the effect of PTH (70%) at 15-min incubation (Fig. 7A ) but did not inhibit the effect of PTH on the activity of Na-K ATPase after 2-h incubation (Fig. 7B) . However, pertussis toxin completely blocked the effect of DA after both 15-min and 2-h incubation (Fig. 7, A  and B) .
DA regulates Na-K ATPase through both DA 1 and DA 2 receptors in proximal tubules. To determine the DA receptor(s) responsible for inhibition of Na-K ATPase in Fig. 5 . Effect of bromoenol lactone (BEL) on the inhibition of Na-K ATPase activity by DA and PTH. OK cell monolayers in 35 ϫ 10-mm plates were incubated in medium containing vehicle, or 1 M BEL for 10 min before treatment with 10 Ϫ5 M DA, or 10 Ϫ7 M PTH for either 15 min (A) or 2 h (B). Na-K ATPase activity was measured in the membranes as described in MATERIALS AND METHODS. Each assay was performed in triplicate, averaged, and considered as a single data point. Values are means Ϯ SE expressed as nmol Pi released ⅐ mg protein Ϫ1 ⅐ h Ϫ1 (n ϭ 3 separate experiments). *P Ͻ 0.01, Na-K ATPase activity significantly different from control. OK cells, the cells were treated with 10 Ϫ5 M SCH-23390 (DA 1 antagonist) or 10 Ϫ7 M sulpiride (DA 2 antagonist) for 30 min before treatment with 10 Ϫ5 M DA. SCH-23390 and sulpiride alone did not effect basal Na-K ATPase activity. Both SCH-23390 (115 and 101%) and sulpiride (106 and 124%) inhibited the effect of DA after 15-min and 2-h incubation, respectively (Fig. 8, A  and B) . The results suggest that DA inhibits Na-K ATPase in OK cells through both DA 1 and DA 2 receptors.
Mapping agonist-stimulated pathways involved in regulation of Na-K ATPase. The previous results implicate several signaling molecules in the regulation of Na-K ATPase: PKA, PKC, and PLA 2 in the case of DA and PKA, and PKC, PLA 2 , and ERK in the case of PTH. The requirement for PKC activation in the short-term regulation of Na-K ATPase suggests that PKC activation may be the initiating step. To map out the remainder of the pathway, OK cells were stimulated with specific activators of PKC or with PLA 2 metabolites after pretreatment with specific inhibitors of the other pathways. Figures 9, A and B, show the effects of inhibitors of PLA 2 and ERK on regulation of Na-K ATPase by PKC activated by 10 Ϫ6 M PMA or by 10 Ϫ6 M PTH(3O34) (a PTH analog that activates PKC but not PKA). Both PMA and PTH(3O34) produced the expected inhibition of Na-K ATPase activity after 15-min incubation. The inhibition by both agents was blocked by preincubation with either the PLA 2 inhibitor BEL or the ERK inhibitor PD-098059. These results suggest that PKC inhibits Na-K ATPase through PLA 2 -and ERK-dependent pathways.
To define the PLA 2 -dependent pathway, OK cells were treated with two metabolites of PLA 2 activity, AA or 20-HETE, under control conditions and after pretreatment with a PKC inhibitor, calphostin C, or an ERK inhibitor, PD-098059. Both AA and 20-HETE inhibited Na-K ATPase activity, as seen in Fig. 10, A and B. Pretreatment with PD-098059 had no effect on Fig. 7 . Effect of pertussis toxin on the inhibition of Na-K ATPase activity by DA and PTH. OK cell monolayers in 35 ϫ 10-mm plates were incubated in medium containing vehicle, or 10 mM pertussis toxin overnight before treatment with 10 Ϫ5 M DA, or 10 Ϫ7 M PTH for either 15 min (A) or 2 h (B). Na-K ATPase activity was measured in the membranes as described in MATERIALS AND METHODS. Each assay was performed in triplicate, averaged, and considered as a single data point. Values are means Ϯ SE expressed as nmol Pi released ⅐ mg protein Ϫ1 ⅐ h Ϫ1 (n ϭ 3 separate experiments). *P Ͻ 0.01, Na-K ATPase activity significantly different from control. . Na-K ATPase activity was measured in the membranes as described in MATERIALS AND METHODS. Each assay was performed in triplicate, averaged, and considered as a single data point. Values are means Ϯ SE expressed as nmol Pi released ⅐ mg protein Ϫ1 ⅐ h Ϫ1 (n ϭ 3 separate experiments). *P Ͻ 0.01, Na-K ATPase activity significantly different from control. the inhibitory effect of either metabolite; however, pretreatment with calphostin C completely abolished inhibition of Na-K ATPase by AA and 20-HETE.
Mechanisms of short-and long-term regulation of Na-K ATPase. Previous investigators have demonstrated that short-term regulation of Na-K ATPase by DA in proximal tubule cells is dependent on phosphorylation of the ␣-subunit followed by endocytosis into clathrincoated vesicles. These processes ultimately result in decreased expression of the subunit, producing longterm inhibition of Na-K ATPase. To determine whether PTH, like DA, decreased expression of the ␣-subunit in OK cells, we immunoblotted membrane proteins from OK cells for the ␣-subunit of Na-K ATPase and for phosphoserine after treatment with PTH(1O34), PTH(3O34), DA, 20-HETE, PMA, and 8-BrcAMP. Figure 11A shows that 15-min incubation with all agonists did not alter the expression of Na-K ATPase. Immunoblotting with the phosphoserine antibody in Na-K ATPase-immunoprecipitated membranes showed increased phosphorylation, especially with PTH(1O34), PTH(3O34), DA, 20-HETE, and AA (Fig. 11B) . Figure 11C shows the results of 2-h incubation, demonstrating a marked decrease in expression of the ␣-subunit in response to all agonists. Consequently, the phosphoserine immunoblot shows no phosphorylation (Fig. 11D) .
Effect of PTH and DA on basolateral membrane expression of Na-K ATPase. For the study of the effect of PTH and DA on basolateral membrane expression of Na-K ATPase, cells were grown on membrane inserts placed in six-well plates to optimize cell polarization and treated with PTH(1O34 or 3O34) and DA. Immunoblot analysis of isolated basolateral membranes showed that DA, but not PTH, decreased the basolateral expression of Na-K ATPase (Fig. 12) after 15 min of treatment.
DISCUSSION
The function of the renal Na-K ATPase is central to the regulation of all transport processes in the proximal renal tubule. Although many hormones regulate transport processes through alterations in specific membrane transporter expression and function, sev- . Na-K ATPase activity was measured in the membranes as described in MATERIALS AND METHODS. Each assay was performed in triplicate, averaged, and considered as a single data point. Values are means Ϯ SE expressed as nmol Pi released ⅐ mg protein Ϫ1 ⅐ h Ϫ1 (n ϭ 3 separate experiments). *P Ͻ 0.01, Na-K ATPase activity significantly different from control. eral hormones exert a more global regulation of proximal renal tubule transport through alterations in the activity of the Na-K ATPase. For example, insulin (18) and norepinephrine (35) increase Na-K ATPase activity, thereby increasing proximal renal tubule sodium reabsorption and preserving extracellular fluid volume. In contrast, DA (2) and PTH (43) inhibit Na-K ATPase activity, resulting in decreased proximal renal tubule sodium reabsorption and decreased extracellular fluid volume. Not surprisingly, the pathways regulating Na-K ATPase activity are numerous, often redundant, and often antagonistic. Furthermore, regulatory mechanisms activated by several of the hormones can differ depending on the length of time of exposure to specific hormonal influences.
Previous publications investigating the regulation of Na-K ATPase in several models of proximal renal tubule, including OK cells, have yielded conflicting results. Some investigators have demonstrated an increase in Na-K ATPase activity after activation of PKA or PKC, whereas others have demonstrated a decrease. Our studies concur with the latter result. The explanation for these conflicting results is not immediately apparent, but they may be due to differences in the technique for measuring Na-K ATPase activity or differences in the several models of proximal tubule. Many of the reports showing an increase in Na-K ATPase measure activity as rubidium uptake, whereas we have measured enzyme activity directly in membrane preparations. Discrepancies in methodology, however, cannot fully explain this controversy, as the opposing effects on Na-K ATPase by PKA and PKC have been confirmed by demonstrating concurrent appropriate increases or decreases in epithelial transport. In some instances, different time points have been chosen for measurement of Na-K ATPase. We have chosen 15 min and 2 h on the basis of previous reports demonstrating the time course for phosphorylation of subunits (short-term regulation) and decreased expression of subunits (long-term regulation).
It is of interest to compare the mechanisms of DA and PTH on the regulation of the proximal renal tubule Na-K ATPase, as both agonists inhibit the activity of the Na-K ATPase, inhibit sodium-dependent hydrogen exchange, and inhibit sodium-dependent phosphate uptake. Because the characteristics of their inhibition of phosphate transport differ significantly, we considered the possibility that differences in the regulation of Na-K ATPase by DA and PTH could account for some of these differences (3, 29) . In fact, we did find significant similarities and differences in the mechanisms activated by PTH and by DA to inhibit Na-K ATPase in OK cells. PTH and DA inhibited Na-K ATPase similarly after 15 min and 2 h. Our findings agree with previous reports showing a biphasic inhibition of Na-K ATPase activity by PTH and DA. The initial, shortterm inhibition is mediated by PKC, whereas the longterm inhibition is mediated predominantly by PKA. For both PTH and DA, short-term inhibition is associated with an increase in phosphoserine labeling of the Na-K ATPase ␣-subunit, whereas long-term inhibition is accompanied by downregulation of the subunit expression. Our findings confirm previous reports that short-term regulation by PTH is quantitatively less than that seen with long-term regulation (38) (39) (40) . However, previous reports have failed to show as we have here that short-term regulation by DA is also quantitatively less than long-term regulation (38) . The reasons for this discrepancy are not clear. One possibility is that the concentration of DA used activates ␣-adrenergic receptors as well as DA receptors, which might have the opposite effects on Na-K ATPase activity (29) . This would not explain why the inhibition of Na-K ATPase activity by DA differs at the two time points, unless the effect of ␣-adrenergic stimulation on Na-K ATPase is transient. Our studies also confirm that short-term and long-term regulation of Na-K ATPase activity by PTH and DA were dependent on PLA 2 activity (14, 34, 36) in OK cells, a situation similar to renal tubular cells. We have demonstrated that inhibition of Na-K ATPase by DA involves both DA 1 and DA 2 receptors, as has been shown in proximal renal tubule cells (38) .
PTH and DA inhibition of Na-K ATPase differed in several respects. Inhibition of Na-K ATPase activity by DA, but not PTH, was blocked by pretreatment with pertussis toxin. This finding is not surprising in view of the well-established coupling of the PTH/PTHrP receptor predominantly to G s and G q , with little coupling to G i (25, 27) . DA receptors couple with pertussis toxinsensitive G proteins (26) . Another significant difference between PTH and DA regulation of Na-K ATPase activity is that PTH, but not DA, regulation was dependent on ERK activity. We have previously reported that PTH inhibition of phosphate uptake is dependent, in part, on ERK activation, whereas inhibition of phosphate uptake by DA is not (30) . These data suggest that PTH inhibits sodium-dependent phosphate uptake, in part, by inhibition of Na-K ATPase through an ERK-dependent pathway. ERK regulates Na-K ATPase in other cell types (22) . ERK regulation of Na-K ATPase in renal cells has not been reported until now.
How PTH-but not DA-stimulated ERK could play a role in the regulation of Na-K ATPase is not apparent.
Previous studies from other laboratories suggest that PKC activation is the final step in the pathway stimulated by DA and PTH, directly phosphorylating the ␣-subunit, leading to its endocytosis. In this scenario, PTH or DA activates phospholipase C, resulting in activation of PLA 2 (31) . The products of PLA 2 stimulation activate PKC (34, 36) . We demonstrated that inhibition of Na-K ATPase by PLA 2 metabolites is blocked by PKC inhibition. Our data, however, also suggest the possibility of a more upstream site of action for PKC. PTH-stimulated ERK is blocked by inhibition of PKC, suggesting that PKC activation occurs before ERK activation (30) . In this study we have shown that inhibition of Na-K ATPase activity by PKC activation through PMA or PTH(3O34) can be blocked by inhibitors of PLA 2 and ERK, suggesting also that PKC is an upstream event. PTH-stimulated phospholipase C could activate PKC (4, (11) (12) (13) (19) (20) , leading to sequential activation of PLA 2 and/or ERK. Such a mechanism for PLA 2 activation has been reported in other cell types (reviewed in Ref. 31 ). Activated PLA 2 may then stimulate a second PKC activation, activating either the same or a different PKC (15, 32) . Alternatively, simultaneous PKC and ERK activation may be required for full inhibition of Na-K ATPase through parallel additive pathways. Further analysis of the signal pathways will be required to answer these questions.
We demonstrated that 15-min treatment with DA, but not PTH, diminishes basolateral membrane expression of the ␣-subunit of Na-K ATPase. Total cellular expression remains unchanged after short-term treatment with both agonists. After 2 h, PTH and DA both decrease expression of the ␣-subunit. Previous investigators have demonstrated that DA stimulates endocytosis of Na-K ATPase proteins into clathrin- coated vesicles. This has not been shown for PTH. Our findings suggest that, in all likelihood, PTH downregulates ␣-subunit expression through a different pathway.
In summary, we have demonstrated that PTH and DA inhibit Na-K ATPase by some similar and some different mechanisms in proximal renal tubule cells, possibly accounting for some of the differences in PTH and DA regulation of tubular transport.
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